Key takeaways:
Wegovy (semaglutide), a prescription-only medication for chronic weight management, has a list price of about $1,350 for a 28-day supply. This means that the medication could cost more than $16,000 per year without insurance or manufacturer discounts.
Coverage for weight-loss medications such as Wegovy varies widely among insurance plans.
A manufacturer savings program may help reduce your cost for Wegovy. If you have commercial insurance that covers Wegovy, you could pay as little as $0 for a 28-day supply of the medication (for up to 13 fills).
Wegovy (semaglutide), an under-the-skin injection, was FDA-approved in 2021 for chronic weight management, making it the first medication to receive such an approval since 2014. Wegovy was also approved in March 2024 to help prevent heart attacks, strokes, and heart-related deaths in adults with a cardiovascular condition and either overweight or obesity. At that time, it became the first weight-loss medication to gain this indication.
Insurance coverage for Wegovy varies widely among insurance plans. Without coverage, Wegovy can cost around $16,000 or more annually. Wegovy also doesn’t have a generic equivalent, meaning there isn’t a more affordable version available. Even so, there are ways to save.
The list price for Wegovy is about $1,350 for a 28-day supply, which adds up to about $16,200 annually. However, due to pharmacy markups, you could end up paying between $1,500 and $2,000 for your prescription every month if you are paying entirely out of pocket.
If you have health insurance that covers Wegovy or qualify for a manufacturer savings program, you may be able to pay much less. For example, if you have commercial insurance and qualify for the Wegovy Savings Card, you may be able to pay as little as $0 per month for up to 13 fills. Consider using a GoodRx coupon to make your prescription more affordable and asking your prescriber about free samples.
In general, many factors can affect how much you pay out of pocket for Wegovy, including:
Pharmacy
Insurance coverage status
Location
Prescribed dosage
Eligibility for patient assistance programs or manufacturer savings cards
Given that Wegovy is typically prescribed for long-term use, the out-of-pocket costs can add up fast. There’s no generic available, either, so Wegovy prices are expected to remain high.
Coverage for obesity care and weight-loss medications varies widely among insurance plans.
For example, Cigna, a private insurance company, covers Wegovy if it is considered medically necessary for weight loss, but you must meet all the criteria. Some Blue Cross Blue Shield plans also cover Wegovy for members who meet plan eligibility requirements.
Medicare plans are prohibited by law from covering prescription medications taken solely for weight loss. However, if you take Wegovy to reduce the risk of a heart condition, it may be covered. As mentioned, Wegovy was FDA-approved in March 2024 to reduce the risk of a life-threatening cardiovascular event in certain adults.
Wegovy is also among 15 medications covered under Medicare Part D selected for price negotiations in 2025. Negotiated prices with participating drug companies will become effective in 2027 in conjunction with the Inflation Reduction Act.
Here’s what to expect for weight-loss medication coverage with a few common insurance options.
Type of insurance | Expected coverage for weight-loss medications |
---|---|
Employer-sponsored insurance | Coverage varies. If your plan doesn’t offer coverage, you may be able to work with your prescriber to write a letter requesting coverage. |
Medicare | Medications prescribed solely for weight-loss purposes are not covered. But you may receive coverage for medically accepted indications, such as heart attack and stroke prevention. |
U.S. Department of Veterans Affairs (VA) health benefits | Inclusion criteria include participating in a comprehensive lifestyle intervention, such as the MOVE! Weight Management Program. |
Tricare (military) insurance | Tricare covers Wegovy for weight management. You must get a prescription from a licensed provider and meet the criteria. Your healthcare professional must also fill out a prior authorization form. |
Individual/family coverage via the Affordable Care Act (ACA, also known as Obamacare) | Coverage varies. ACA marketplace plans aren’t required to offer obesity medication coverage, but some plans may. |
If you have Medicaid, your coverage will depend on where you live. Insurance coverage policies for weight-management medications such as Wegovy are evolving. You can go to the “Check your insurance coverage” page on NovoCare’s website, click “I am a patient,” and choose “Medicaid” to see if your state’s program covers the medication.
These state Medicaid programs currently cover Wegovy for people 12 years or older unless otherwise indicated:
California
Delaware
Georgia (for people 12 to 21 years old)
Hawaii (not all plans)
Indiana (for people 12 to 21 years old)
Kansas
Massachusetts
Michigan
Minnesota
Mississippi
New Hampshire
North Carolina (for people 12 to 21 years old)
Oregon (for people 12 to 21 years old)
Pennsylvania
Rhode Island (not all plans)
Tennessee (for people 12 to 21 years old)
Virginia
Wisconsin
Keep in mind that your insurer may require a prior authorization or have you try other treatments before you can get coverage for Wegovy.
Looking for ways to save on prescription medications? From patient assistance programs to GoodRx coupons, there are many ways to get help paying for your medications.
Medicare does not cover medications taken solely for weight loss. However, you may be eligible for coverage if you meet these requirements.
Medicaid coverage varies by state. Find out if Medicaid covers weight-loss medications in your state.
No. A generic version isn’t available. And there probably won’t be one for quite a while because patent terms are set at 20 years. Wegovy remains under an active patent in China until 2026 and in the U.S. until 2032.
There are other prescription medications that contain semaglutide, the active ingredient in Wegovy. But they aren’t FDA-approved for chronic weight management. Another Novo Nordisk medication, Ozempic, which is approved to help people with Type 2 diabetes manage their blood glucose (sugar) levels, also contains semaglutide — but at a lower dose than Wegovy. Rybelsus is an oral version of semaglutide that’s also approved for blood glucose control in people with Type 2 diabetes.
Because Wegovy is FDA-approved for chronic weight management, many insurance providers won’t cover it. However, following the three steps below could increase your chances of getting Wegovy covered under your insurance plan:
Review your health insurance plan. Find out what, if any, insurance coverage your provider offers for treatments for weight loss or chronic weight management, including prescription medications. Check your plan’s formulary to see if Wegovy is listed as a covered medication. If necessary, contact your insurance provider and ask for coverage details.
Schedule an appointment with your healthcare professional. Wegovy is in a medication class called glucagon-like peptide 1 (GLP-1) receptor agonists and is meant to be used alongside a nutritious diet and routine exercise. Ask your prescriber if they can write a letter to your insurance plan outlining why Wegovy is medically necessary for your care. Then, submit it to your insurance provider for its review, or ask your prescriber to submit it.
Appeal for reconsideration. If your insurance provider denies your first request for coverage, you can file an appeal. Check your insurance plan for details on the appeal process, which will likely involve sending an appeal letter that outlines why Wegovy is necessary to your overall health.
For people whose commercial insurance covers Wegovy, the manufacturer offers a savings program that covers up to 13 fills of a 28-day supply (four injectable pens) of the medication. With the savings offer, you could pay as little as $0 for each eligible 28-day supply.
Program website | https://www.novocare.com/obesity/products/wegovy/savings-offer.html |
Phone number | |
Manufacturer | Novo Nordisk |
How much can I save? | If you have commercial insurance, you could pay as little as $0 per month for up to 13 fills, with maximum savings of $225 per 28-day supply, $450 per 56-day supply, or $675 per 84-day supply. |
How do I get the discount? | Sign up for the offer on the program’s website. |
Are there any restrictions? | This discount is only available to people with a valid prescription who live in the U.S. People covered by government-sponsored programs — such as Medicaid, Medicare, Medigap, Tricare, or VA benefits — aren’t eligible. |
What if I don’t have insurance? | All eligible cash-paying customers can pay $499 per 28-day supply, $998 per 56-day supply, or $1,497 per 84-day supply at their local pharmacy. Note: Since your prescription will be processed outside your insurance with the savings offer, your purchase will not count toward deductibles and can’t be applied to any insurance maximum out-of-pocket limits. |
You can apply for a Wegovy Savings Card on the NovoCare website. You’ll be asked questions about your prescription status, insurance coverage, and other eligibility requirements.
You can download a Wegovy coupon by searching for the medication on the GoodRx website, entering your prescription information, and choosing your location and pharmacy.
Wegovy is available in pharmacies across the U.S. for those with a prescription. If you are interested in getting a prescription for Wegovy, you can do the following:
Reach out to a prescriber. Make an appointment with a prescriber to discuss your health and weight-management goals. Based on your medical history, needs, and health status, they can help you determine if Wegovy is a good option for you.
Obtain a medical exam. A prescriber may want to give you a physical exam to determine your current health status before recommending a weight-loss medication. To qualify for a Wegovy prescription, you must have obesity or an overweight condition and at least one weight-related medical condition.
Decide on a treatment plan. If a prescriber determines that Wegovy is an option for you, they will talk you through a treatment plan, which will likely include making lifestyle changes. They will also provide details about potential side effects and how to use the medication.
Schedule follow-up care. If you receive a prescription for Wegovy and start treatment, your prescriber may ask you to return for follow-up care, so they can monitor your progress and address any concerns you may have.
You may also be able to get a prescription for Wegovy online, using a telehealth service. However, the service may charge fees or require you to enroll in a subscription or membership program to meet with a prescriber.
It’s important to note that increased demand for Wegovy has resulted in a shortened supply in the past. You can get updates about Wegovy’s supply status on Novo Nordisk’s website.
Wegovy’s list price is about $1,350 per package, while Ozempic’s list price is about $998. Your out-of-pocket costs will depend on several factors, such as insurance coverage, location, and pharmacy.
With the Wegovy Savings card, you can get the medication for as little as $0 for up to 13 boxes of 28-day supplies if you have commercial insurance coverage for Wegovy. The maximum savings is $225 for one box, $450 for two boxes, or $675 for three boxes.
Many insurance companies and employers that provide health care coverage don’t consider weight-loss medications medically necessary. Coverage may also vary based on your insurance plan’s formulary, prior authorization requirements, or the availability of more affordable alternatives. Check with your insurer to understand its required criteria and documentation. Medicare is prohibited by law from covering prescription medications taken solely for weight loss.
Wegovy (semaglutide) is a medication for chronic weight management designed to be used with a healthy diet and exercise. The list price is around $1,350 for a 28-day supply, but the medication can cost even more out of pocket due to pharmacy markups. If you have commercial insurance and meet certain criteria, you may pay as little as $0 for a 28-day supply for up to 13 fills with the Wegovy Savings Card. Regardless of your insurance status, you can use a GoodRx coupon for potential savings on Wegovy.
Blue Cross Blue Shield of Massachusetts. (2025). Pharmacy medical policy: Drugs for weight loss and cardiovascular risk reduction in overweight and obesity.
Centers for Medicare & Medicaid Services. (2025). HHS announces 15 additional drugs selected for Medicare drug price negotiations in continued effort to lower prescription drug costs for seniors.
Cigna Healthcare. (2024). Weight loss – glucagon-like peptide-1 agonists prior authorization policy.
Gomez, G., et al. (2017). US health policy and prescription drug coverage of FDA-approved medications for the treatment of obesity. International Journal of Obesity.
Lee, G. (2024). The battle for billions: Understanding the Ozempic patent landscape. Science and Technology Law Review.
NovoCare. (n.d.). Find out the cost for Ozempic.
NovoCare. (n.d.). Terms and conditions of use: Standard savings offer.
NovoCare. (n.d.). What is the list price for Wegovy and will it impact me?
Novo Nordisk. (2025). Novo Nordisk expands Wegovy $499-per-month offering to additional cash-paying patients via the Wegovy savings offer. PR Newswire.
Obesity Medicine Association. (2023). Does insurance cover weight loss medication?
Office of Health Policy. (2024). Medicare coverage of anti-obesity medications. Office of the Assistant Secretary for Planning and Evaluation.
TRICARE. (2024). Does TRICARE cover Wegovy, Ozempic, and Mounjaro?
U.S. Department of Veterans Affairs. (2024). MOVE! Weight Management Program.
U.S. Department of Veterans Affairs. (2024). Semaglutide (Wegovy) criteria for use April 2024.
U.S. Food and Drug Administration. (2020). Frequently asked questions on patents and exclusivity.
U.S. Food and Drug Administration. (2020). FDA approves new drug treatment for chronic weight management, first since 2014.
U.S. Food and Drug Administration. (2024). FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight.
Vafiadis, D. (2024). Obesity treatment and Medicare: A guide to understanding coverage. National Council on Aging.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.